Historical Stock Price
ETFs Holding NBY »    NBY Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
02/19/2021 $1.53 $1.58 $1.22 $1.27 12.96M
02/22/2021 $1.32 $1.62 $1.23 $1.42 24.68M
02/23/2021 $1.24 $1.30 $1.13 $1.17 8.80M
02/24/2021 $1.22 $1.31 $1.21 $1.24 3.44M
02/25/2021 $1.23 $1.23 $1.10 $1.12 4.38M
NovaBay Pharmaceuticals is a medical device company primarily focused on eye care. Co. is focused on commercializing Avenova®, a product sold in the U.S. for cleansing and removing foreign material including microorganisms and debris from skin around the eye, including the eyelid. Avenova is formulated with Co.'s proprietary hypochlorous acid. Co. has developed additional products, including NeutroPhase® for the wound care market and CelleRx® for the dermatology market. Co.'s second product category includes auriclosene, its key clinical-stage Aganocide compound, which is a synthetic molecule with a spectrum of uses against bacteria, viruses and fungi.
NBY historical stock prices picture
NovaBay Pharmaceuticals (NBY) has the following price history information. Looking back at NBY historical stock prices for the last five trading days, on February 19, 2021, NBY opened at $1.53, traded as high as $1.58 and as low as $1.22, and closed at $1.27. Trading volume was a total of 12.96M shares. On February 22, 2021, NBY opened at $1.32, traded as high as $1.62 and as low as $1.23, and closed at $1.42. Trading volume was a total of 24.68M shares. On February 23, 2021, NBY opened at $1.24, traded as high as $1.30 and as low as $1.13, and closed at $1.17. Trading volume was a total of 8.80M shares. On February 24, 2021, NBY opened at $1.22, traded as high as $1.31 and as low as $1.21, and closed at $1.24. Trading volume was a total of 3.44M shares. On February 25, 2021, NBY opened at $1.23, traded as high as $1.23 and as low as $1.10, and closed at $1.12. Trading volume was a total of 4.38M shares.

NBY Historical Stock Prices By Date:

NBY historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into NovaBay Pharmaceuticals shares, starting with a $10,000 purchase of NBY, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 02/28/2011
End date: 02/25/2021
Start price/share: $53.75
End price/share: $1.12
Dividends collected/share: $0.00
Total return: -97.92%
Average Annual Total Return: -32.10%
Starting investment: $10,000.00
Ending investment: $208.30
Years: 10.00
Date Close
02/19/2021$1.27
02/22/2021$1.42
02/23/2021$1.17
02/24/2021$1.24
02/25/2021$1.12
NBY is categorized under the Healthcare sector; below are some other companies in the same sector:

NDRA Historical Stock Prices
NDZ Historical Stock Prices
NEO Historical Stock Prices
NEOG Historical Stock Prices
NEOS Historical Stock Prices
NEOT Historical Stock Prices
NERV Historical Stock Prices
NHC Historical Stock Prices
NK Historical Stock Prices
NKTR Historical Stock Prices

NBY Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.